3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ketosis
1
Insulin Resistance
1
Glioma
1
Glioblastoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
38
Radiotherapy
17
Filgrastim
14
Surgical Procedures, Operative
11
Irinotecan
11
Carmustine
10
Carboplatin
10
Radiation
9
O(6)-benzylguanine
9
Magnetic Resonance Spectroscopy
9
Specimen Handling
7
Granulocyte Colony-Stimulating Factor
7
Flucytosine
7
sargramostim
6
Radiotherapy, Intensity-Modulated
5
Peripheral Blood Stem Cell Transplantation
5
Etoposide
5
Erlotinib Hydrochloride
5
Bevacizumab
5
vocimagene amiretrorepvec
4
Vorinostat
4
Thiotepa
4
Melphalan
4
Lenalidomide
4
IL13-PE38
4
Genetic Therapy
4
Cyclophosphamide
4
Chemotherapy, Adjuvant
4
Busulfan
4
lonafarnib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Astrocytoma
×
Hypoglycemic Agents
×
Clear all
NCT02149459
2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1
Unknown
18 enrolled